Fuzail, Anjum

Fuzail, Anjum was paid $55K by Medicaid between Jan 2021 and Jul 2022, across 10 billing codes. Its largest line is G2023, Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source — 33% of everything it billed.

33Billing provider infoFUZAIL, ANJUM
SCHAUMBURG, IL 60193

33aNPI1407886419assigned 07/04/2006

33bProvider typePediatrics Physician

28Total paid$55K

24GClaims2,157

24DCodes billed10

24AFirst – last monthJan 2021 – Jul 2022

Compared with peers

Next to other Pediatrics Physician providers in Illinois

Rank by total paid#904 of 1,805

Median peer was paid$55K

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	1,194	$29K
2022	963	$26K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	33%	787	668	$18K
Q3014	Telehealth originating site facility fee	24%	665	560	$13K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	17%	277	256	$9K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	16%	250	191	$9K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	5.5%	86	83	$3K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.9%	14	12	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	15	13	$375.00
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	15	15	$364.80
99072		<1%	29	29	$56.25
99001		0%	19	19	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.